Literature DB >> 15369771

Regulation of activities of NK cells and CD4 expression in T cells by human HNP-1, -2, and -3.

Kun Zhang1, Qinghua Lu, Qian Zhang, Xun Hu.   

Abstract

Human neutrophil defensin alpha (HNP) is a group of cationic peptides of diverse physiological roles. Recent studies revealed the nature of HNPs as the dominant HLA-DR binding peptides on malignant cancer cells, which may block the major histocompatibility complex for antigen presentation. Here we show that HNPs may inhibit T cells by downregulating CD4 expression, a molecule of critical importance for T cell's interaction with the target cell. HNPs also inhibited tumor-cell-lysis activities of NK cells by downregulating CD16-CD56 expression. More importantly, HNPs were markedly elevated in 14 cancer tissues out of 15 self-paired human colorectal cancers and their adjacent noncancerous tissues. The subset compositions of HNPs extracted from cancer tissues and neutrophils were identical. Immunohistochemical studies indicated that HNPs mainly distributed in the infiltrated neutrophils in the interstitium. The elevated HNPs in cancer tissues may create a microenvironment unfavorable for adaptive immune reaction, implicating the cancer evasion. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15369771     DOI: 10.1016/j.bbrc.2004.08.111

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  Multifunctional antimicrobial peptides: therapeutic targets in several human diseases.

Authors:  Mohamed Zaiou
Journal:  J Mol Med (Berl)       Date:  2007-01-10       Impact factor: 4.599

2.  Defensin alpha 6 (DEFA 6) overexpression threshold of over 60 fold can distinguish between adenoma and fully blown colon carcinoma in individual patients.

Authors:  Mariya Y Radeva; Franziska Jahns; Anne Wilhelm; Michael Glei; Utz Settmacher; Karl Otto Greulich; Henning Mothes
Journal:  BMC Cancer       Date:  2010-10-27       Impact factor: 4.430

3.  Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides.

Authors:  Lars Steinstraesser; Bettina Tippler; Janine Mertens; Evert Lamme; Heinz-Herbert Homann; Marcus Lehnhardt; Oliver Wildner; Hans-Ulrich Steinau; Klaus Uberla
Journal:  Retrovirology       Date:  2005-01-18       Impact factor: 4.602

4.  Stochastic model of contact inhibition and the proliferation of melanoma in situ.

Authors:  Mauro César Cafundó Morais; Izabella Stuhl; Alan U Sabino; Willian W Lautenschlager; Alexandre S Queiroga; Tharcisio Citrangulo Tortelli; Roger Chammas; Yuri Suhov; Alexandre F Ramos
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.379

Review 5.  Immunomodulatory properties of defensins and cathelicidins.

Authors:  D M E Bowdish; D J Davidson; R E W Hancock
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

Review 6.  The role of defensins in virus-induced asthma.

Authors:  David Proud
Journal:  Curr Allergy Asthma Rep       Date:  2006-02       Impact factor: 4.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.